MRT-81 is a potent smoothened (SMO) receptor antagonist effective in both human and rodent systems, inhibiting Hedgehog signaling with an IC50 of 41 nM in Shh-Light2 cells. This compound is a valuable research tool for studying the Hedgehog pathways role in cancer, applicable in both in vitro and in vivo experimental models.